Cargando…

Decreased plasma DEK Oncogene Levels Correlate with p16-Negative Disease and Advanced Tumor Stage in a Case–Control Study of Patients with Head and Neck Squamous Cell Carcinoma

Head and neck cancer (HNC) remains the sixth most common malignancy worldwide and survival upon recurrence and/or metastasis remains poor. HNSCC has traditionally been associated with alcohol and nicotine use, but more recently the Human Papilloma Virus (HPV) has emerged as a favorable prognostic ri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wise-Draper, Trisha, Sendilnathan, Arun, Palackdharry, Sarah, Pease, Nicholas, Qualtieri, Julianne, Butler, Randall, Sadraei, Nooshin Hashemi, Morris, John C., Patil, Yash, Wilson, Keith, Mark, Jonathan, Casper, Keith, Takiar, Vinita, Lane, Adam, Privette Vinnedge, Lisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2017
Materias:	Original article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6002348/ https://www.ncbi.nlm.nih.gov/pubmed/29289845 http://dx.doi.org/10.1016/j.tranon.2017.12.001

Ejemplares similares

Dissecting the Potential Interplay of DEK Functions in Inflammation and Cancer
por: Pease, Nicholas A., et al.
Publicado: (2015)

The DEK Oncogene Is a Target of Steroid Hormone Receptor Signaling in Breast Cancer
por: Privette Vinnedge, Lisa M., et al.
Publicado: (2012)

DEK Expression in Breast Cancer Cells Leads to the Alternative Activation of Tumor Associated Macrophages
por: Pease, Nicholas A., et al.
Publicado: (2020)

The human DEK oncogene stimulates beta catenin signaling, invasion and mammosphere formation in breast cancer
por: Privette Vinnedge, Lisa M., et al.
Publicado: (2011)

The DEK oncogene promotes cellular proliferation through paracrine Wnt signaling in Ron receptor positive breast cancers
por: Privette Vinnedge, Lisa M., et al.
Publicado: (2014)

DEK promotes HPV positive and negative head and neck cancer cell proliferation
por: Adams, Allie K., et al.
Publicado: (2014)

Novel molecular mechanisms in Alzheimer’s disease: The potential role of DEK in disease pathogenesis
por: Greene, Allie N., et al.
Publicado: (2022)

Loss of DEK Expression Induces Alzheimer’s Disease Phenotypes in Differentiated SH-SY5Y Cells
por: Greene, Allie N., et al.
Publicado: (2020)

PB2164: PROGNOSTIC IMPACT OF ONCOGENE DEK IN DIFFUSE LARGE B-CELL LYMPHOMA
por: Alonso Alonso, R., et al.
Publicado: (2022)

The human DEK oncogene regulates DNA damage response signaling and repair
por: Kavanaugh, Gina M., et al.
Publicado: (2011)

Determining the molecular landscape and impact on prognosis in HPV-associated head and neck cancer
por: Khanna, Suchin, et al.
Publicado: (2020)

A phase I/II trial of concurrent immunotherapy with chemoradiation in locally advanced larynx cancer
por: Frankart, Andrew J., et al.
Publicado: (2022)

DEK is required for homologous recombination repair of DNA breaks
por: Smith, Eric A., et al.
Publicado: (2017)

Overexpression of the human DEK oncogene reprograms cellular metabolism and promotes glycolysis
por: Matrka, Marie C., et al.
Publicado: (2017)

Human Papillomavirus and Survival of Sinonasal Squamous Cell Carcinoma Patients: A Systematic Review and Meta-Analysis
por: Sharma, Anish, et al.
Publicado: (2021)

IRAK1 is a novel DEK transcriptional target and is essential for head and neck cancer cell survival
por: Adams, Allie K., et al.
Publicado: (2015)

Role of the DEK oncogene in the development of squamous cell carcinoma
por: Ishida, Kazuhisa, et al.
Publicado: (2020)

Oncolytic virotherapy for head and neck cancer: current research and future developments
por: Malhotra, Akshiv, et al.
Publicado: (2015)

Metformin increases natural killer cell functions in head and neck squamous cell carcinoma through CXCL1 inhibition
por: Crist, McKenzie, et al.
Publicado: (2022)

Potential of DEK proto-oncogene as a prognostic biomarker for colorectal cancer: An evidence-based review
por: Habiburrahman, Muhammad, et al.
Publicado: (2022)

Oncogene DEK is highly expressed in lung cancerous tissues and positively regulates cell proliferation as well as invasion
por: Zhou, Qian-Cheng, et al.
Publicado: (2018)

Promotion of cell proliferation by the proto‐oncogene DEK enhances oral squamous cell carcinogenesis through field cancerization
por: Nakashima, Takayuki, et al.
Publicado: (2017)

Small extravesicular microRNA in head and neck squamous cell carcinoma and its potential as a liquid biopsy for early detection
por: Galiveti, Chenna R., et al.
Publicado: (2022)

An Open‐Label Phase II Trial of Bevacizumab plus Docetaxel and Gemcitabine in Advanced, Previously Untreated Nonsquamous Non‐Small Cell Lung Cancer
por: Patil, Pradnya Dinkar, et al.
Publicado: (2019)

Defective transcription elongation in human cancers imposes targetable proteotoxic vulnerability
por: Muhammad, B., et al.
Publicado: (2021)

The DEK oncogene activates VEGF expression and promotes tumor angiogenesis and growth in HIF-1α-dependent and -independent manners
por: Zhang, Yanan, et al.
Publicado: (2016)

The SAF-box domain of chromatin protein DEK
por: Böhm, Friederike, et al.
Publicado: (2005)

A DEK domain-containing protein GhDEK2D mediated Gossypium hirsutum enhanced resistance to Verticillium dahliae
por: Zhou, Jinglong, et al.
Publicado: (2022)

The role of DEK protein in hepatocellular carcinoma for progression and prognosis
por: Lin, Li-juan, et al.
Publicado: (2013)

The DEK Oncoprotein Functions in Ovarian Cancer Growth and Survival()
por: Hacker, Kari E, et al.
Publicado: (2018)

DEK-targeting DNA aptamers as therapeutics for inflammatory arthritis
por: Mor-Vaknin, Nirit, et al.
Publicado: (2017)

Drug resistance mechanisms create targetable proteostatic vulnerabilities in Her2+ breast cancers
por: Singh, Navneet, et al.
Publicado: (2022)

Dek overexpression in murine epithelia increases overt esophageal squamous cell carcinoma incidence
por: Matrka, Marie C., et al.
Publicado: (2018)

Oncoprotein DEK as a tissue and urinary biomarker for bladder cancer
por: Datta, Antara, et al.
Publicado: (2011)

High expression of DEK predicts poor prognosis of gastric adenocarcinoma
por: Piao, Junjie, et al.
Publicado: (2014)

Characterization of Enlarged Kidneys and Their Potential for Inducing Diabetes in DEK Rats
por: Domon, Ayaka, et al.
Publicado: (2021)

Profile of pembrolizumab in the treatment of head and neck squamous cell carcinoma: design development and place in therapy
por: Haque, Sulsal, et al.
Publicado: (2017)

Comprehensive microRNA-sequencing of exosomes derived from head and neck carcinoma cells in vitro reveals common secretion profiles and potential utility as salivary biomarkers
por: Langevin, Scott, et al.
Publicado: (2017)

Therapeutic Advancements in Metal and Metal Oxide Nanoparticle-Based Radiosensitization for Head and Neck Cancer Therapy
por: Dubey, Poornima, et al.
Publicado: (2022)

PD1 blockade enhances K(+) channel activity, Ca(2+) signaling, and migratory ability in cytotoxic T lymphocytes of patients with head and neck cancer
por: Newton, Hannah S, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lhoigmtch6rqse20dfo6ehtkgq